Gapping up
In reaction to strong earnings/guidance: COMM +14.2% (also upgraded to Buy from Hold at Jefferies), TRMR +8.1%, SSTK +6.8%, ARUN +6.7% (also announces additional $200 mln share repurchase authorization), FUEL +6.1%, JOBS +5.1% (light volume), DISH +5.1%, PCYC +5%, BBG +4.1% (light volume), TTS +3.5%, (ticking higher), WBMD +3.4%, UEIC +3.1%, (thinly traded),PGI +2.7%, (light volume), DXCM +2.5%, WBAI +2.1%, INTU +1.9%, CVT +1.8%, HPQ +1.7%, PCLN +1.5%, QLIK +1%, COG +0.7%, ( announces new agreements for long-term sales and pipeline takeaway capacity).
M&A news: ESC +34% and BKD +1.5% (Emeritus Corp and Brookdale Senior Living sign definitive merger agreement; Emeritus shareholders will receive 0.95 shares of Brookdale common stock in exchange for each share of their Emeritus common stock; exchange ratio implies a 32% premium on Emeritus' shares), IOC +6.1% (InterOil seeing uptick in after hours trading, up nearly 3%; potentially related to DailyMail story that co is a strong takeover target), AXE +1.5% (following late spike on PE speculation).
Other news: ISIS +5.7% (reports interim results from ISIS-SMN Rx; average increase of 3.7 points observed in muscle function score in SMA children treated with 9 mg of ISIS-SMN Rx; on track to initiate Phase 3 study in children with SMA later this year), MVIS +4.9% (continued strength), CTIC +4.1% (still checking), AMRC +3.3% (among companies awarded $7 bln govt contract), ARIA +2.4% (expands Its Board of Directors with appointment of Alexander J. Denner of Sarissa Capital Management), CONN +2.2% (modestly rebounding), FANG +1.8% (prices public offering of 3 mln shares of common stock at $62.67 per share), DDD +1.5% (still checking), JNPR +1.4% (announces integrated operating plan; says enhanced operational efficiency expected to result in a 25% operating margin for 2015; aggressive capital return plan returning a minimum of $3 bln of capital to shareholders over the next three years, including more than $2 bln in share repurchases through Q1 2015; co to initiate $0.10 per share quarterly dividend to commence in Q3 2014), NOK +1.2% (still checking), AMZN +1.1% (is offering retailers to post links back to retailers websites on AMZN, according to reports ), RBS +1.1% (to eliminate 30K investment banking jobs, according to reports ), NVS +0.9% (announced Lucentis approval in fourth Japanese indication, diabetic macular edema; Pivotal clinical data in Asian patients show a significant increase in mean visual acuity following treatment with Lucentis compared with laser therapy), VOD +0.7% (still checking), KO +0.6% (announces letters of intent with two new bottling partners).
Analyst comments: AEG +3.1% (upgraded to Strong Buy from Outperform at Raymond James), STX +2.3% (upgraded to Outperform at RBC Capital Mkts; tgt raised to $60), BCRX +1.5% (initiated with a Overweight at Piper Jaffray; tgt $17) SDRL +1.3% (upgraded to Overweight from Neutral at HSBC ), TOT +0.8% (upgraded to Neutral from Sell at Goldman).
M&A news: ESC +34% and BKD +1.5% (Emeritus Corp and Brookdale Senior Living sign definitive merger agreement; Emeritus shareholders will receive 0.95 shares of Brookdale common stock in exchange for each share of their Emeritus common stock; exchange ratio implies a 32% premium on Emeritus' shares), IOC +6.1% (InterOil seeing uptick in after hours trading, up nearly 3%; potentially related to DailyMail story that co is a strong takeover target), AXE +1.5% (following late spike on PE speculation).
Other news: ISIS +5.7% (reports interim results from ISIS-SMN Rx; average increase of 3.7 points observed in muscle function score in SMA children treated with 9 mg of ISIS-SMN Rx; on track to initiate Phase 3 study in children with SMA later this year), MVIS +4.9% (continued strength), CTIC +4.1% (still checking), AMRC +3.3% (among companies awarded $7 bln govt contract), ARIA +2.4% (expands Its Board of Directors with appointment of Alexander J. Denner of Sarissa Capital Management), CONN +2.2% (modestly rebounding), FANG +1.8% (prices public offering of 3 mln shares of common stock at $62.67 per share), DDD +1.5% (still checking), JNPR +1.4% (announces integrated operating plan; says enhanced operational efficiency expected to result in a 25% operating margin for 2015; aggressive capital return plan returning a minimum of $3 bln of capital to shareholders over the next three years, including more than $2 bln in share repurchases through Q1 2015; co to initiate $0.10 per share quarterly dividend to commence in Q3 2014), NOK +1.2% (still checking), AMZN +1.1% (is offering retailers to post links back to retailers websites on AMZN, according to reports ), RBS +1.1% (to eliminate 30K investment banking jobs, according to reports ), NVS +0.9% (announced Lucentis approval in fourth Japanese indication, diabetic macular edema; Pivotal clinical data in Asian patients show a significant increase in mean visual acuity following treatment with Lucentis compared with laser therapy), VOD +0.7% (still checking), KO +0.6% (announces letters of intent with two new bottling partners).
Analyst comments: AEG +3.1% (upgraded to Strong Buy from Outperform at Raymond James), STX +2.3% (upgraded to Outperform at RBC Capital Mkts; tgt raised to $60), BCRX +1.5% (initiated with a Overweight at Piper Jaffray; tgt $17) SDRL +1.3% (upgraded to Overweight from Neutral at HSBC ), TOT +0.8% (upgraded to Neutral from Sell at Goldman).